coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Burnley East PCN, Burnley · Health Inequalities Profile

    PCN U31823 · NHS Lancashire and South Cumbria Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    55,338

    Registered population

    59.1% aged 18–64

    18.6%

    Aged 65+

    ICB 20.0% · England 17.9%

    21.8%

    Ethnic minority (non-White)

    18.9% Asian · England 9.6%

    51.1%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~25,421

    Core20 residents (est.)

    Resident basis; registered basis ~29,060 · see page 3

    9,056

    Hypertension register

    +6.10% in 3 yrs · England +5.60%

    577

    SMI register

    47.7% of Burnley's

    1,488

    COPD register

    Reviews +4.23% in 3 yrs

    Forecast to 2030

    10,484

    Hypertension patients, 2030

    +1,428 on today

    67.9%

    QRISK ≥20% on statins, 2030

    +3.79pp over 3 yrs

    4.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    59.5%
    High-risk lipid therapy trails national and local benchmarks.

    Only 59.5% of patients with QRISK ≥ 20% receive lipid-lowering therapy, below Burnley (61.3%), the ICB (61.4%), and England (63.6%).

    9.6 pp
    Pre-school MMR2 and 4-in-1 boosters fall short.

    Age-5 MMR coverage drops 9.6 pp from dose 1 (94.3%) to dose 2 (84.7%), with 4-in-1 at 82.2% against the 95.0% target.

    73.2%
    Hypertension, COPD, and SMI checks exceed England.

    Hypertension treated to target reaches 73.2% (England 70.3%), alongside 83.4% COPD review coverage (England 76.4%) and 89.3% SMI BP checks (England 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Children comprise 22.3% and Asian residents 18.9%, with marked concentration across practices

    Across six practices and 55,338 registered patients, 22.3% are aged 0-17 (Burnley 22.5%, ICB 19.6%, England 19.6%) and 18.6% are aged 65+ (Burnley 16.7%, ICB 20.0%, England 17.9%). Census usual-resident ethnicity shows an Asian / Asian British share of 18.9% (Burnley 14.7%, ICB 9.4%, England 9.6%), concentrated at Colne Road Surgery (49.9%) compared to Burnley Wood Medical Centre (5.2%). White residents represent 78.2% (Burnley 82.5%, ICB 87.8%, England 81.1%). Registered patient ethnicity may differ from resident Census bases.

    Age profile

    0–1722.3%
    18–6459.1%
    65+18.6%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White78.2%
    Asian18.9%
    Mixed1.7%
    Other0.9%
    Black0.4%

    Older people · falls rows are Burnley local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Burnley LA)1,7462,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.1%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)56.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Burnley LA)6751,0219552024/25
    Falls deaths, all ages, per 100,000 (Burnley LA)14.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 51.1% overall but spans 77.5 percentage points between practices

    Across the PCN, 51.1% of registered patients live in Core20 areas, compared to Burnley (52.5%), NHS Lancashire and South Cumbria Integrated Care Board (30.6%), and England (21.0%). Across captured practices, the range is 77.5 pp. Briercliffe Surgery records 8.0%, while Colne Road Surgery records 85.4%. Parkside Surgery holds the largest volume at 7,941 estimated Core20 patients. Delivery requires dual targeting across practice concentration and absolute patient volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Colne Road85.4% · 7,238 patients
    Burnley Wood61.4% · 4,324 patients
    Yorkshire Street57.8% · 4,191 patients
    Thursby55.5% · 4,709 patients
    Parkside50.2% · 7,941 patients
    Briercliffe8.0% · 657 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    577

    SMI register

    1.03% recorded prevalence

    375

    Learning disability register

    0.67% recorded prevalence

    32

    Care homes, 957 beds

    In the PCN catchment

    9.9%

    Provide unpaid care

    Burnley, Census 2021

    Recorded prevalence is 1.0% for severe mental illness (577 patients; England 1.0%) and 0.7% for learning disability (375 patients; England 0.6%). Catchment care homes total 32 with 957 beds. In wider system measures, Burnley recorded 6 people sleeping rough in autumn 2025 (a borough snapshot), alongside a PCN ceiling estimate of 5,478 unpaid carers.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reach 89.3% (England 83.4%) and BMI checks reach 88.3% (England 82.1%). Over three years, BMI checks rose +2.7 pp (England +5.1 pp).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    9,056

    Hypertension register

    +6.10%

    Register growth, 3 yrs

    Burnley +7.94% · England +5.60%

    +3.30pp

    BP control, under 80

    ≤140/90 · +2.48pp aged 80+

    +1,428

    More patients by 2030

    Forecast 10,484 (18.28%)

    Hypertension case-finding and control

    Burnley East PCN records 9,056 patients on its hypertension register (16.2% prevalence), below Burnley (16.3%) and NHS Lancashire and South Cumbria Integrated Care Board (17.2%), but above England (15.2%). Practice prevalence ranges from 11.6% at Colne Road Surgery to 17.7% at Parkside Surgery. Treatment to target reaches 73.2%, exceeding England (70.3%). Recent blood pressure checks cover 92.2% (England 90.0%), with three-year growth at +2.6% (England +3.6%). An unverified projection estimates 10,484 cases by 2030, a projected change of 1,428. Recorded prevalence variation between practices may reflect local case-mix or case-finding practices, testable through audit.

    Lipids and statins

    Patients with QRISK ≥ 20% treated with lipid lowering therapy reach 59.5%, below England (63.6%), Burnley (61.3%), and NHS Lancashire and South Cumbria Integrated Care Board (61.4%). Prescribed items per 1,000 for lipid-regulating drugs (18+, 2026) stand at 2,504 (England 4,100). Lower therapy rates among high-risk patients could reflect recall gaps, testable via clinical audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026107,621£1.70£1.64£1.86£182,956
    Cardiovascular (all), 2025154,271£3.37£3.38£3.33£519,893

    In 2026, the PCN prescribed 107,621 items for lipid-regulating drugs at £1.70 per item (Burnley £1.58, NHS Lancashire and South Cumbria Integrated Care Board £1.64, England £1.86). Across these items, the PCN spent £17,219 less than at England's unit cost, and £6,457 more than at the ICB's unit cost. Unit cost differences do not reflect treatment quality or clinical efficiency.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +14.40%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −4.27%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.7% (1,488 patients; England 1.9%), with 83.4% reviewed in the last 12 months (England 76.4%). Asthma prevalence is 7.6% (3,952 patients; England 6.6%), falling 4.3% over three years (England +0.5%). Asthma review coverage is 74.8% (England 65.7%), leaving an estimated 998 patients without a recorded review. Asthma management items prescribed per 1000 5-19 population are 1,543 (England 1,488). Review gaps could reflect recall tracking differences, unverified locally.

    Cancer register and children's immunisation

    Cancer prevalence is 3.8% (2,119 patients; England 3.8%). In Q1 2025/26, MMR dose 1 coverage at age 5 reached 94.3% (England 91.7%), while MMR dose 2 was 84.7% (England 82.8%), a dose difference of 9.6 pp. The 4-in-1 pre-school booster reached 82.2%, below the 95.0% target by 12.8 pp across 157 children. Dose differences may reflect pre-school recall attrition, unverified locally.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months93.0%

    England 91.0%

    6-in-1 complete primary course at 24 months91.0%

    England 92.2%

    MMR dose 1 at 24 months90.2%

    England 88.3%

    MMR dose 2 at age 584.7%

    England 82.8%

    4-in-1 pre-school booster at age 582.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, NHS Lancashire and South Cumbria ICB diagnosed 52.4% of cancers at stage 1 or 2 among known-stage cases (4,642 of 8,863), 22.6 pp below the 75.0% national ambition (England 55.3%). Known-stage completeness was 74.6% (8,863 of 11,883 cases; England 67.0%). Across the ICB, early-stage share fell 1.2 pp from 2013 to 2022, requiring about 2,010 extra early-stage cases annually to reach 75.0%. This describes the wider system, not PCN delivery. Locally, PCN cervical screening coverage (25-49 yrs) is 66.8%, with a 2023 to 2025 change of -2.6% (England -1.0%), reaching 47.8% at Colne Road Surgery. Lagging screening uptake risks delayed detection, testable via practice recall audit.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Lancashire Hospitals NHS Trust met the 28-day faster diagnosis standard at 81.5% (standard 75.0%; Northern Care Alliance NHS Foundation Trust 75.2%, Airedale NHS Foundation Trust 87.7%, ICB 78.4%, England 79.3%) and the 31-day standard at 98.1% (standard 96.0%; ICB 93.6%, England 92.5%). On the 62-day referral to treatment standard, it reached 73.2% against the 85.0% target (ICB 73.6%, England 71.2%). Diagnostic 6+ week waits were 0.4% for MRI and 0.1% for CT (England 21.4% and 9.9%). Provider data reflects wider system capacity, not PCN performance.

    Pathways within standard (%)East LancashireNorthern Care AllianceAiredaleLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5075.2087.7178.3979.32
    31-day treatment (96%)98.1194.5498.2093.6292.50
    62-day referral to treatment (85%)73.1678.6588.8973.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireNorthern Care AllianceAiredaleEngland
    MRI0.435.092.9121.40
    CT0.154.100.009.92
    Echocardiography0.0031.480.7028.48
    Colonoscopy0.9540.0431.2130.83
    Gastroscopy1.1636.4822.9829.02
    All 15 DM01 tests3.2515.714.3323.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In June 2026 (provisional), community health service activity recorded 126,445 total contacts for borough residents. Contacts with adults aged 65 and over accounted for 56.9% of this activity (72,000 contacts), reflecting substantial older-adult demand within the wider community care system.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, practice overall QOF achievement ranged from 90.4% at Parkside Surgery to 98.2% at Yorkshire Street Medical Centre. Clinical domain achievement reached 98.1% at Briercliffe Surgery. Vaccination and immunisation achievement spanned 72.2 pp, from 15.6% at Parkside Surgery to 87.8% at Yorkshire Street Medical Centre (England 55.2%). Variation across practices was wider in vaccination and immunisation than overall clinical.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Parkside Surgery12350.238.4%60.4%79.5%
    Yorkshire Street10657.881.4%58.0%79.4%
    Burnley Wood10661.463.1%65.1%73.9%
    Briercliffe928.067.9%62.8%72.5%
    Colne Road Surgery9385.461.0%82.7%70.2%
    Thursby Surgery9255.542.1%85.1%68.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBurnleyAssetPCNBurnley
    Care homes (catchment)32 (957 beds)n/aSchools (catchment)97n/a
    Children's centres56Places of worship4654
    Libraries56Homelessness support (VCS)11
    Primary schools (LA maintained)2226Primary academies66
    Special schools22

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review and recall

    Asthma review coverage is 74.8% (Burnley 67.8%, England 65.7%), leaving an estimated 998 of 3,952 asthma patients unreviewed, while three-year prevalence fell 4.3% (England +0.5%). For discussion: run a single-template asthma recall and register coding audit, pairing flexible review slots with inhaler checks. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    High-risk lipid and hypertension audit

    QRISK ≥ 20% lipid therapy is 59.5% (Burnley 61.3%, ICB 61.4%, England 63.6%); hypertension prevalence is 16.2% (ICB 17.2%), from 11.6% at Colne Road Surgery to 17.7% at Parkside Surgery. For discussion: run a pharmacist-led recall of untreated QRISK ≥ 20% patients alongside opportunistic blood pressure checks. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Pre-school booster recall and alignment

    In Q1 2025/26 (157 children), age-5 MMR2 is 84.7% vs 94.3% for MMR1 (9.6 pp difference) and 4-in-1 is 82.2%; QOF vaccination achievement spans 72.2 pp (15.6% to 87.8%). For discussion: audit age-5 children who had MMR1 without MMR2 or 4-in-1, aligning practice call-recall workflows. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Tailored language and communication outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall review (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Targeted hypertension case finding (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review and recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · High-risk lipid and hypertension audit (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 3 · Pre-school booster recall and alignment (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15